Daiichi Sankyo Stock Hits Day High with Strong 4.26% Intraday Surge

Daiichi Sankyo Co., a prominent player in the Pharmaceuticals & Biotechnology sector, has shown significant activity today, gaining 4.26% as of June 18, 2026. The stock reached an intraday high of JPY 2,706.00, reflecting a notable performance against the backdrop of the Japan Nikkei 225, which rose by 1.65% on the same day. Over the past week, Daiichi Sankyo has demonstrated a robust performance with an 8.46% increase, although it has lagged behind the Nikkei 225's 10.65% rise. In the longer term, the stock has faced challenges, with a one-year performance decline of 21.66%, contrasting sharply with the Nikkei's impressive 82.73% gain. Despite these fluctuations, Daiichi Sankyo maintains a net-debt-free status and has reported healthy long-term growth, with net sales increasing at an annual rate of 16.32% and operating profit rising by 33.85%. The company boasts a return on equity of 17.81% and a price-to-book ratio of 2.76, indicating an attractive valuation relative to its peers.